星空体育官方入口网站网址大全-登录入口官网

#肿瘤活性#

40篇内容 | 1088人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2034552, encodeId=768620345521f, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=中药及活性成分可以发挥抗肿瘤活性，抑制肝癌, objectType=article, longId=726474, objectId=a1f1e2647499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f1e2647499, replyNumber=0, likeNumber=66, createdTime=2022-07-17, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f1e2647499, moduleTitle=中药及活性成分可以发挥抗肿瘤活性，抑制肝癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a1f1e2647499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034550, encodeId=8552203455049, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Clin Cancer Res：PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性, objectType=article, longId=220797, objectId=5c23220e97c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c23220e97c1, replyNumber=0, likeNumber=0, createdTime=2022-05-01, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c23220e97c1, moduleTitle=Clin Cancer Res：PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c23220e97c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034551, encodeId=13c4203455119, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Lancet Oncol：尼拉帕利在DNA修复基因缺陷的转移性去势抵抗性前列腺癌中的抗肿瘤活性, objectType=article, longId=295173, objectId=79422951e301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79422951e301, replyNumber=0, likeNumber=59, createdTime=2022-08-15, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79422951e301, moduleTitle=Lancet Oncol：尼拉帕利在DNA修复基因缺陷的转移性去势抵抗性前列腺癌中的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79422951e301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034553, encodeId=8b8620345532f, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Molecular Therapy-Oncolytics：李鹏/李扬秋合作发现提升CAR-T细胞抗异质性肿瘤活性新方法, objectType=article, longId=733032, objectId=c71fe3303267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c71fe3303267, replyNumber=0, likeNumber=73, createdTime=2023-05-10, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c71fe3303267, moduleTitle=Molecular Therapy-Oncolytics：李鹏/李扬秋合作发现提升CAR-T细胞抗异质性肿瘤活性新方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c71fe3303267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034554, encodeId=4b8b203455465, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=中科院在提升CAR-T细胞抗异质性肿瘤活性方面取得新进展, objectType=article, longId=733438, objectId=99ece33438eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99ece33438eb, replyNumber=0, likeNumber=68, createdTime=2022-08-23, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99ece33438eb, moduleTitle=中科院在提升CAR-T细胞抗异质性肿瘤活性方面取得新进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=99ece33438eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034548, encodeId=6004203454850, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Lancet Oncol：PARP抑制剂Talazoparib在晚期转移性去势抵抗性前列腺癌中的抗肿瘤活性, objectType=article, longId=215592, objectId=aefb21559219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aefb21559219, replyNumber=0, likeNumber=0, createdTime=2022-02-26, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aefb21559219, moduleTitle=Lancet Oncol：PARP抑制剂Talazoparib在晚期转移性去势抵抗性前列腺癌中的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aefb21559219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034549, encodeId=8fe2203454949, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Clin Cancer Res：卡瑞珠单抗+法米替尼在晚期肾癌中表现出有效且持久的抗肿瘤活性, objectType=article, longId=216259, objectId=c9c62162592f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9c62162592f, replyNumber=0, likeNumber=51, createdTime=2021-11-16, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9c62162592f, moduleTitle=Clin Cancer Res：卡瑞珠单抗+法米替尼在晚期肾癌中表现出有效且持久的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c9c62162592f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034547, encodeId=8550203454e11, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Clin Cancer Res：Wee1抑制剂Adavosertib(AZD1775)在晚期实体肿瘤患者中的抗肿瘤活性及相关生物标志物, objectType=article, longId=214645, objectId=1284214645f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1284214645f5, replyNumber=0, likeNumber=69, createdTime=2021-09-20, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1284214645f5, moduleTitle=Clin Cancer Res：Wee1抑制剂Adavosertib(AZD1775)在晚期实体肿瘤患者中的抗肿瘤活性及相关生物标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1284214645f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034544, encodeId=a12a203454486, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Nat Commun：地西他滨处理CAR-T细胞，能增强其抗肿瘤活性, objectType=article, longId=206197, objectId=a7aa20619ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7aa20619ebe, replyNumber=0, likeNumber=53, createdTime=2021-09-04, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7aa20619ebe, moduleTitle=Nat Commun：地西他滨处理CAR-T细胞，能增强其抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a7aa20619ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034546, encodeId=17c0203454615, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Lancet oncol：Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期, objectType=article, longId=211377, objectId=f1712113e75f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1712113e75f, replyNumber=0, likeNumber=48, createdTime=2022-01-31, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1712113e75f, moduleTitle=Lancet oncol：Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1712113e75f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034543, encodeId=5f11203454310, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=ASCO GI 2020：Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, objectType=article, longId=205972, objectId=009f2059e2f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009f2059e2f7, replyNumber=0, likeNumber=59, createdTime=2021-06-08, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009f2059e2f7, moduleTitle=ASCO GI 2020：Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=009f2059e2f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034541, encodeId=437f203454193, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Lancet oncol：RAF-MEK抑制剂在携带RAS/RAF突变的多种肿瘤中的抗肿瘤活性, objectType=article, longId=202766, objectId=2fe5202e6622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fe5202e6622, replyNumber=0, likeNumber=67, createdTime=2021-04-21, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fe5202e6622, moduleTitle=Lancet oncol：RAF-MEK抑制剂在携带RAS/RAF突变的多种肿瘤中的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2fe5202e6622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034542, encodeId=822b2034542eb, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Blood：水杨酸盐可增强CRM1抑制剂的抗肿瘤活性, objectType=article, longId=203481, objectId=9f55203481b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f55203481b5, replyNumber=0, likeNumber=130, createdTime=2020-12-19, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f55203481b5, moduleTitle=Blood：水杨酸盐可增强CRM1抑制剂的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f55203481b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034545, encodeId=dea82034545d6, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Clin Cancer Res：PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性, objectType=article, longId=206884, objectId=a7cd206884c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7cd206884c6, replyNumber=0, likeNumber=52, createdTime=2021-08-18, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7cd206884c6, moduleTitle=Clin Cancer Res：PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a7cd206884c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034539, encodeId=f46420345396f, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Nat Immuno: 找到免疫治疗好帮手了！科学家发现，抑制CD36可阻断调节T细胞对肿瘤微环境的适应，增强抗肿瘤活性, objectType=article, longId=191006, objectId=817819100609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817819100609, replyNumber=0, likeNumber=66, createdTime=2020-07-31, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817819100609, moduleTitle=Nat Immuno: 找到免疫治疗好帮手了！科学家发现，抑制CD36可阻断调节T细胞对肿瘤微环境的适应，增强抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=817819100609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034538, encodeId=7cc0203453804, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Blood：hnCD16-iNK细胞的抗肿瘤活性, objectType=article, longId=185065, objectId=e4711850656f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4711850656f, replyNumber=0, likeNumber=64, createdTime=2020-08-25, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4711850656f, moduleTitle=Blood：hnCD16-iNK细胞的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e4711850656f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034540, encodeId=e3582034540a5, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=抗PVRIG抗体COM701在早期研究中显示出抗肿瘤活性, objectType=article, longId=193094, objectId=3ff319309444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ff319309444, replyNumber=0, likeNumber=72, createdTime=2020-10-05, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ff319309444, moduleTitle=抗PVRIG抗体COM701在早期研究中显示出抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ff319309444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034537, encodeId=3693203453ee4, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Blood：Epo刺激T细胞可增强过继性T细胞疗法的抗肿瘤活性, objectType=article, longId=182245, objectId=ac0518224573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac0518224573, replyNumber=0, likeNumber=97, createdTime=2020-05-15, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac0518224573, moduleTitle=Blood：Epo刺激T细胞可增强过继性T细胞疗法的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ac0518224573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034533, encodeId=36a620345333d, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=CLIN CANCER RES：整合素β3阻滞可以增强ALK抑制剂抗肿瘤活性, objectType=article, longId=148809, objectId=3f8b1488090c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f8b1488090c, replyNumber=0, likeNumber=57, createdTime=2019-06-25, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f8b1488090c, moduleTitle=CLIN CANCER RES：整合素β3阻滞可以增强ALK抑制剂抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f8b1488090c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034534, encodeId=346f20345340b, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Int J Mol Sci：在膀胱癌中，以CD46为靶标能够增加腺病毒5型的抗肿瘤活性, objectType=article, longId=150277, objectId=336b1502e723, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336b1502e723, replyNumber=0, likeNumber=61, createdTime=2019-01-30, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336b1502e723, moduleTitle=Int J Mol Sci：在膀胱癌中，以CD46为靶标能够增加腺病毒5型的抗肿瘤活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=336b1502e723)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤活性

2020-05-29

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

中药及活性成分可以发挥抗肿瘤活性，抑制肝癌

2022-07-17

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Clin Cancer Res：PD-L1抗体单药或联合TIM-3抗体在MSI-H/dMMR晚期肿瘤中的抗肿瘤活性和安全性

2022-05-01

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Lancet Oncol：尼拉帕利在DNA修复基因缺陷的转移性去势抵抗性前列腺癌中的抗肿瘤活性

2022-08-15

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Molecular Therapy-Oncolytics：李鹏/李扬秋合作发现提升CAR-T细胞抗异质性肿瘤活性新方法

2023-05-10

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

中科院在提升CAR-T细胞抗异质性肿瘤活性方面取得新进展

2022-08-23

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Lancet Oncol：PARP抑制剂Talazoparib在晚期转移性去势抵抗性前列腺癌中的抗肿瘤活性

2022-02-26

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Clin Cancer Res：卡瑞珠单抗+法米替尼在晚期肾癌中表现出有效且持久的抗肿瘤活性

2021-11-16

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Clin Cancer Res：Wee1抑制剂Adavosertib(AZD1775)在晚期实体肿瘤患者中的抗肿瘤活性及相关生物标志物

2021-09-20

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Nat Commun：地西他滨处理CAR-T细胞，能增强其抗肿瘤活性

2021-09-04

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Lancet oncol：Cemiplimab在局部晚期基底细胞癌中的抗肿瘤活性令人可期

2022-01-31

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

ASCO GI 2020：Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性

2021-06-08

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Lancet oncol：RAF-MEK抑制剂在携带RAS/RAF突变的多种肿瘤中的抗肿瘤活性

2021-04-21

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Blood：水杨酸盐可增强CRM1抑制剂的抗肿瘤活性

2020-12-19

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Clin Cancer Res：PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性

2021-08-18

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Nat Immuno: 找到免疫治疗好帮手了！科学家发现，抑制CD36可阻断调节T细胞对肿瘤微环境的适应，增强抗肿瘤活性

2020-07-31

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Blood：hnCD16-iNK细胞的抗肿瘤活性

2020-08-25

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

抗PVRIG抗体COM701在早期研究中显示出抗肿瘤活性

2020-10-05

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Blood：Epo刺激T细胞可增强过继性T细胞疗法的抗肿瘤活性

2020-05-15

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

CLIN CANCER RES：整合素β3阻滞可以增强ALK抑制剂抗肿瘤活性

2019-06-25

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Int J Mol Sci：在膀胱癌中，以CD46为靶标能够增加腺病毒5型的抗肿瘤活性

2019-01-30

科室
- - 订阅+
  - 更多科室
工具
服务